chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1 day later - sore arm. 1 week out - intense ovulation cramping then two days later started bleeding heavily for approx three days - 2 weeks early for menstruation. Nausea and IBS symptoms every day since.
Ascending paresthesias and paralysis; started one week after vaccination in back and legs and by the time of presentation had ascending up to abdomen and bilateral arms, now with facial weakness.
arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), ALPRAZOLAM (XANAX) and ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm soreness). On 18-Feb-2021, PAIN IN EXTREMITY (arm soreness) had resolved. Not Provided          No treatment information was provided.   This case was linked to MOD-2021-051416 (Patient Link).
double dose of the booster shot; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL OVERDOSE (double dose of the booster shot) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In November 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. In November 2021, the patient experienced ACCIDENTAL OVERDOSE (double dose of the booster shot). In November 2021, ACCIDENTAL OVERDOSE (double dose of the booster shot) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter enquired whether it was safe to get 4th booster.  No concomitant medications were reported. No treatment medications were provided.
Expired vaccine administered; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter. It was reported that vaccine expired on 3 Apr 2022 was administered to total of 24 patients including 15 males and 9 females. The administrations were mostly for booster shots. No side effects was reported. No treatment information was provided by the reporter.
SLEEPY, FATIGUE, HEADACHE Narrative: SYMPTOMS LASTED X 3 DAYS  Other Relevant History:
Shortly after influenza vaccine given, patient found to be diaphoretic, pale, dizzy. As time progresses, symptoms abate.
Patient experienced fever with redness, warmth, and discomfort in left arm around injection site the day after vaccination (12/3/22). Which he presented to the emergency room and was given a diagnosis of Cellulitis. He was prescribed Cephalexin which he came and pickup up the morning of 12/4/22.  He indicated being given a dose of antibiotic at the hospital and was able to break his fever and was feeling better. He is going to visit with his PCP in the next week or so when they can get him in for follow-up.
I developed a fatigue, virus infection, sore throat and I was dizzy when I am standing up and occasionally short of breath. Because all this stuff and the sore throat I tested myself and I was positive on the May holiday. My wife also was positive, my daughter was negative. On Tuesday, I email my doctor and I had an online visit, but I did not take any medicine. I just quarantine.
Shingles rash noted 12 days after receiving vaccine. I have had shingles earlier this year so I was familiar and able to contact my care provider.
Arm started to be sore early afternoon after receiving the vaccine that morning.  By that night, redness around the injection site started. This was about quarter size.  The area was sore to touch.,  The next day I experienced generalized malaise and muscle aches.  It is now 6 days post injection and I still have redness quarter size/half dollar size around injection site, but the redness has faded some.
For details obtain records from the hospital.  In brief child was doing well after vaccines until late evening when apparently two seizures occurred.  Our office was not envolved with care and details are not known. Patient was seen on follow-up after hospital discharge and continues to be seizure free.DOS 8/5-8/6/06 DX: ALTE, hypotonic, hyporesponsive episode secondary to DPT immunization and acute afebrile illness. Present illness: limp and unresponsive for 10 minutes prior to ER visit. Another episode in ER limp and unresponsive for another 10-15 minutes. Lips turned blued, no jerking episode noloss of bowel or bladder control. No fever. Temp in ER 99.9. Stools light green in color diarrhea no blood in stool.  PE: Erythema or tonsils no exudates remainder of exam WNL.
Faculty member stated that while she was eating lunch (30 minutes after having received the H1N1 vaccine) she began to feel dizzy. School nurse took patient's blood pressure, which was initially 170/100 @ 1:20 PM; 152/90 @ 1:25 PM; and 132/70 @ 1:30 PM (faculty member was lying on L side on health room bed). She (the faculty member) stated that she had been out of her BP medication and "did not have any to take this morning."
Pt's niece came to pharmacy 10/19/15 and said her aunt (the patient) had experienced generalized pain at site of injection and has a softball size bruise at the injection site.
Aortic valve replacement. The patient was discharged on ASA and beta blocker therapy. The patient was discharged with an Rx for cephalexin for dental prophylaxis. The patient will need this indefinitely. Hospital admission within 6 weeks of receiving the COVID vaccine.
Pt reported increased fatigue, body aches, generalized not feeling well for 24hrs after vaccine. Reports soreness redness at injection site which redness after 72hrs is worsening, pruritus is developing today 9/1/18, increased warmth and mild swelling are worsening in the area today 9/1/2018. Pt was prescribed triamcinolone cream for site pruritus, CLARITIN 10mg daily in am, and to take BENADRYL 25mg at bedtime and as needed. She applied topical NEOSPORIN to area the past 1-2 days.
Miscommunication between staff and client receiving immunization. Client was to receive her second dose of COVID-19 vaccine primary series, however, she was given Pfizer Bivalent.
This case was reported by a other health professional via sales rep and described the occurrence of injection site rash in a 11-year-old patient who received MENVEO (batch number M155097, expiry date unknown). On an unknown date, the patient received MENVEO. On an unknown date, an unknown time after receiving MENVEO, the patient experienced injection site rash and injection site hives. The patient was treated with ZYRTEC. On an unknown date, the outcome of the injection site rash and injection site hives were recovered/resolved. It was unknown if the reporter considered the injection site rash to be related to MENVEO. The reporter considered the injection site hives to be probably related to MENVEO. Additional details provided were as follows: The patient experienced rash and hives at the injection site following vaccination with MENVEO. The Rash or hives described as being up and down the left arm. The patient's mom administered ZYRTEC but rash or hives began resolving prior to ZYRTEC. Issues now resolved.
Woke up with a very sore arm, severe headache, and swollen, red upper right eyelid. Gave Tylenol for pain. Headache and arm pain resolved within 24 hours.  Eyelid still red, sore and swollen over 72 hours later. Using warm compresses with little relief. Trying Benadryl now, too soon to report outcome.
patient reported itching and swelling/redness in arm below administration site (lower forearm) about 10 minutes after administration. Patient was given 25mg diphenhydramine and monitored. Issue resolved and patient was released from care at 12:18pm.
At 11:20 PM, I was about to go to bed when I started to get cold on my hands.  Then I became cold all over and had worsening chills throughout the night.  I could not get warm despite lots of blankets and clothing.  I was shivering all through the night until about 5:00 AM. I did not sleep well at all  I woke up not feeling well, with my both hip joints aching.  That is  unusual for me.  I have a low-grade fever and am very tired.  No chills at this time.  This in addition to soreness at the injection site.
Itchy, hot, red bumps around vaccination site. Eight days after injection. Lasted for two hours. Subsided.
Lump at vaccine site, warm to touch, red circle with red ring around it, itching
Initially soreness at the site of the injection, some dizziness, fatigue, double vision.
Severe pain in armpit and lymph nodes around the shoulder of arm that vaccine was administered in.  Pain radiates into breast.
Chronic pain, neuropathy, immobility, high temperatures, hemorrhoid vascular events, mental fog, eye strain.
Moderna COVID?19 Vaccine  2.5 cm raised hard  red patch, warm to touch, soreness  directly underneath the injection site    this started an hour after the injection (1/4/21) and stayed for 2 1/2 days (1/6/21).   I noticed it came back on the 7th day 1/11/21  red raised patch  same size same place  slightly itchy.
Patient reported (after the fact) heart palpitations and the sensation of the throat closing a went to the hospital.
Patients left injection site arm hurts; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Patients left injection site arm hurts) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048L21A, 002B21A, 007M20A and 048F21A) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.   On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 20-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 19-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 28-Mar-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. In March 2022, the patient experienced VACCINATION SITE PAIN (Patients left injection site arm hurts). At the time of the report, VACCINATION SITE PAIN (Patients left injection site arm hurts) outcome was unknown.            No concomitant drug reported. No treatment information was provided by the reporter.  Patient reported her records saying that she received 0.25ml for her booster dose.   This case was linked to MOD-2022-526424, MOD-2022-526395, MOD-2022-526422 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Mar-2022: No newinformation.
Post vax, the pt had immediate numbness of both arms, and one leg. Also, dizziness, nausea, muscle aches, headache, malaise, diarrhea, and sneezing. No fever. It lasted 48 hours and he missed 2 days of work.
Redness at site of injection on left arm and 4 inches below site; itchiness, minor swelling.
Infant started to choke after first few drops on vaccine, stopped and repositioned infant, patted back, allowed infant to recover for a few minutes. Slowly administrated remaining amount. Mom stated infant had similar episode with feed. Instructed mom to keep infant upright after feeds and vaccines.
Pt is having progressive numbness and weakness of left side of body including her tongue. Pt has been sent to neurologist. There is concern the pt may have Guillain Barre. Pt is in the process of treatment. FU on 12/3 from MD states pt is somewhat anxious and has some give away weakness in her legs as well as astasia abasia when walking. Will start her on steriods and ask her to come back in after getting test results. Diagnosed with acute disseminated encephalomyelitis
Rash: right side of face broke out in red maculopapular rash at giving of RotaTeq. No swelling of tongue lips. (note that patient drools a lot and medication dripped on that side of face).
48 hours of adverse effects. Violent chills, extreme dizziness and vomiting. Body aches during the first 24 hours. Sore arm at injection site for 48 hours. Slept all day on day 2.
Pt received Tdap on 4/10/12. She presented to our triage RN on 4/12 complaining of a "knot" on her shoulder. She was seen by me on 4/13/12. She had pain & redness at injection site. Erythema was 4-5 cm in diameter. She also had a < 1 cm (L) supraclavicular lumph node that was tender. She was seen by another doctor on 5/11/12 & lymph node was resolving. (Some fullness in area - but not LAD).
year and a half since first dose/ before the COVID outbreak; This case was reported by a consumer via interactive digital media and described the occurrence of social problem in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.  Additional details were reported as follows: The was reported by the patient. The age at vaccination were not applicable for this report. It's been probably a year and a half since then the patient did not get the second dose of Shingrix.  The patient asked if it was too late to get second shot. Follow-up would not be possible as no contact details available.
myalgias, fatigue,  followed a couple of hours later by somnolence,, nausea, vomiting, abdominal pain, diarrhea all lasting about 36 hours then all resolved except abdominal pain and diarrhea, which are still going on.. Treated symptomatic a Lly. I have no reason to think this was related to the vaccine. Rapid COVID tests at onset and after 48 hours were negative.
This case was reported by a physician via call center representative and described the occurrence of extensive swelling of vaccinated limb in a adult patient who received Influenza vaccine Quadrivalent 2018-2019 season for prophylaxis. On 9th October 2018 10:00, the patient received Influenza vaccine Quadrivalent 2018-2019 season (intramuscular). On 9th October 2018, less than a day after receiving Influenza vaccine Quadrivalent 2018-2019 season, the patient experienced extensive swelling of vaccinated limb and injection site itching. On an unknown date, the outcome of the extensive swelling of vaccinated limb and injection site itching were unknown. It was unknown if the reporter considered the extensive swelling of vaccinated limb and injection site itching to be related to Influenza vaccine Quadrivalent 2018-2019 season. Additional details were provided as follows: The age at vaccination was not reported. After receiving Flu vaccine, the patient experienced itching and swelling over an 8cm by 8cm by 3cm area at the injection. The reporter knows it was a GSK product but was unable to provide the name or any other information at the time of the call. The staff member would call back to provide additional information. This case was transferred to medical information. This case has been linked with the case US2018183707, US2018183712 and US2018GSK186849 reported by same reporter.
had bad body aches for a day; Initial information received on 10-Oct-2020 regarding an unsolicited valid non-serious case from a consumer/non-health care professional via social media.  This case is linked to: 2020SA294158, 2020SA294157 and 2020SA294125.  This case involves a patient of unknown demographics who had bad body aches for a day (pain), after receiving INFLUENZA VACCINE.  The patient's concurrent condition included being allergic to eggs. The patient's medical history, past medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.   On an unknown date (many years ago), the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiration date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient had bad body aches for a day (pain) (non serious) (unknown latency) following the administration of INFLUENZA VACCINE.  No laboratory data reported.  It was not reported if the patient received a corrective treatment.  At the time of report, the patient was recovered from the event.  There will be no information on the batch number for this case.
11/20/21 presents to EC ED for "SOB and cough". PMHx of "COPD, HTN".
fatigue a lot; constipation; little pain in my joints - knees and heels; arm pain; a little fever; feel a little bad; This is a spontaneous report from a contactable healthcare professional. A 52-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 at the age of 52-year-old via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. She got the Pfizer vaccine and reports having experienced arm pain, "a little fever" and "feel a little bad" for one day after the vaccine. She still experiences "fatigue a lot" as well as constipation and "little pain in my joints-knees and heels". The outcome of the events arm pain, "a little fever" and "feel a little bad" was unknown, and not recovered for the rest of the events.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
flue like symptoms; headache; chills; body ache; nausea; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flue like symptoms), HEADACHE (headache), CHILLS (chills), PAIN (body ache) and NAUSEA (nausea) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (flue like symptoms), HEADACHE (headache), CHILLS (chills), PAIN (body ache) and NAUSEA (nausea). At the time of the report, INFLUENZA LIKE ILLNESS (flue like symptoms), HEADACHE (headache), CHILLS (chills), PAIN (body ache) and NAUSEA (nausea) outcome was unknown.            This case was linked to MOD-2021-034624 (Patient Link).
The patient came into the store requesting a vaccine. She completed the screening questionnaire and waited. After administering the vaccine, she was asked to sit in the pharmacy for 10-15 minutes before leaving. She sat in the waiting area for about 2 hours, then started to walk around the store. The patient then fell near the front of the store. She did not say she felt any certain way before leaving the pharmacy area.
no adverse event; Customer reported that a patient received their first dose of ROTATEQ at 6 months of age outside the recommended PI.  No additional AE information no PQC.; This spontaneous report was received from a medical assistant referring to patient of an unknown age and gender. The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies, and concomitant therapies were not reported.  On 10-OCT-2022, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, administered orally for prophylaxis at 6 months of age outside the recommended product label (strength, lot #, and expiry date were not provided) (product administered to patient of inappropriate age). No additional adverse event information was reported.
Patient was given his second Moderna Covid booster dose out of a vial that had been sitting at room temperature for approximately 25 hours. There was no harm to the patient. I have contacted to Moderna to get stability information and to see if patient will need to repeat this dose. I am awaiting an email with this information.
PLEURISY.TWO WEEKS AFTER THE 1ST SHOT, I WAS GETTING IN MY CAR AND HAD A SUDDEN SHARP PAIN IN MY CHEST THAT HURT SO BAD I COULD BARELY MOVE MY SHOULDERS AND ARMS AND HAD A HARD TIME BREATHING.  IT DI; PLEURISY.TWO WEEKS AFTER THE 1ST SHOT, I WAS GETTING IN MY CAR AND HAD A SUDDEN SHARP PAIN IN MY CHEST THAT HURT SO BAD I COULD BARELY MOVE MY SHOULDERS AND ARMS AND HAD A HARD TIME BREATHING.  IT DI; PLEURISY.TWO WEEKS AFTER THE 1ST SHOT, I WAS GETTING IN MY CAR AND HAD A SUDDEN SHARP PAIN IN MY CHEST THAT HURT SO BAD I COULD BARELY MOVE MY SHOULDERS AND ARMS AND HAD A HARD TIME BREATHING.  IT DI; This is a spontaneous report from a contactable consumer or other non-health care professional.  A 21-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/Lot Number: EW017, Expiration date: Unknown), via an unspecified route of administration, in Left Arm on 28May2021 17:00 (at the age of 21-years-old) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history included wheezing, food allergy NUTS, POLLEN, PET DANDER, SHELLFISH, seasonal allergy, allergy to animal, food allergy from an unknown date and unknown if ongoing. The patient concomitant medications were not reported. On 10Jun2021 04:30, the patient had experienced pleurisy. Two weeks after the 1st shot, patient was getting in my car and had a sudden sharp pain in her chest that hurt so bad patient could barely move her shoulders and arms and had a hard time breathing. It dissipated a bit after 20 minutes, but when patient slept, patient turned in my sleep and again the sharp pain hit again and patient could not sleep. patient tried to get comfortable and slept the rest of the night. patient have not seen a medical professional yet because a close family friend had the exact same reaction 2 weeks after her moderna vaccine and walked me through it. She had gone to urgent care and they told her it was pleurisy, which lasted a few days for her. Hopefully it did not get more severe. Outcome of events was recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Pt recvd vax & c/o extreme stinging/burning sensation during immed p/inject of 4th dose; No further c/o sx;
Bad headache, 103° fever, dry eyes, eye pain, both ears hurt, unable to do any activity. Chills,Severe bone, muscle pain, no appetite. Fever rose from 99.2° to 103° during day. Evening sweating, weakness, dizziness